A detailed history of Creekmur Asset Management LLC transactions in Genmab A/S stock. As of the latest transaction made, Creekmur Asset Management LLC holds 79 shares of GMAB stock, worth $1,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79
Previous 79 -0.0%
Holding current value
$1,626
Previous $1.99 Million 2.97%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.13 - $30.27 $1,985 - $2,391
79 New
79 $1.99 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Creekmur Asset Management LLC Portfolio

Follow Creekmur Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creekmur Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creekmur Asset Management LLC with notifications on news.